Opendata, web and dolomites

PUPILOSCOPE SIGNED

Pupiloscope, a Neuro-Critical Care Device, Enabling Quantitative, Real-Time, Pupillary Monitoring and Assessment of Patients with Neurotrauma and Head Injuries.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PUPILOSCOPE project word cloud

Explore the words cloud of the PUPILOSCOPE project. It provides you a very rough idea of what is the project "PUPILOSCOPE" about.

manufacturing    quantitative    ready    medical    error    regulatory    reg    injuries    head    approved    estimate    accurate    secondary    launch    reducing    worldwide    pupiloscope    leaders    healthcare    seek    breakthrough    positively    sales    approval    monitoring    incorporating    people    potentially    million    clinicians    global    validation    globally    brain    device    young    finalisation    prevent    society    engineers    care    health    42    tbi    triage    an    hospital    vivo    levels    proven    emergency    clinically    life    quick    disability    unmet    clinical    societal    economics    neuro    mild    traumatic    time    33    forecasts    markets    prone    death    trl    critical    skill    solution    injury    relatives    functional    paramedics    opinion    annum    doctors    alone    suffer    medicating    threatening    eyes    direct    ce    nurses    successfully    shining    billion    light    victims    outcomes    industry    experts    human    patients    prototype    pupillary    patient    impacting    subjective   

Project "PUPILOSCOPE" data sheet

The following table provides information about the project.

Coordinator
VIVO SMART MEDICAL DEVICES LTD 

Organization address
address: 6 EDISON VILLAGE NOTTINGHAM SCIENCE TECHNOLOGY PARK
city: NOTTINGHAM
postcode: NG7 2RF
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.pupiloscope.com
 Total cost 1˙250˙911 €
 EC max contribution 875˙637 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIVO SMART MEDICAL DEVICES LTD UK (NOTTINGHAM) coordinator 875˙637.00

Map

 Project objective

An estimated 42 million people Worldwide suffer a Head Injury (2.5 million in the EU) that can lead to Mild or Traumatic Brain Injury (TBI). It is a major cause of death and disability, especially in young people, impacting victims and relatives, with significant costs to society, estimated at €33 Billion per annum in Europe alone.

Pre-Hospital and Emergency Care Neuro-Monitoring, including pupillary assessment, is critical in the processes of triage, management and medicating patients to prevent secondary injury to the brain. However, the current method of shining a light into a patient's eyes, in order to estimate pupillary response, is subjective and prone to human error.

The solution is Pupiloscope®, enabling Accurate, Real-time, Quantitative Pupillary Monitoring and Assessment for patients with potentially life threatening head injuries. Pupiloscope is a breakthrough technology that will positively impact clinical pathways as well as patient outcomes. It is quick, simple, and easy to use by Doctors, Nurses and Paramedics of all skill levels. Through collaboration with industry experts, key opinion leaders, engineers and Emergency Care based clinicians, who identified the unmet clinical need, ViVO has successfully developed a functional prototype to TRL 6.

As a direct result of this project, Pupiloscope forecasts sales of €20 Million within 5 years of product launch, improving patient outcomes and reducing both the societal and costs of care in the EU and Globally by an estimated €2 Billion per annum.

This project will seek to develop Pupiloscope into a clinically proven, manufacturing ready and CE approved medical device; incorporating technology finalisation, regulatory approval, health economics, clinical testing and validation, therefore enabling product launch and sales to the EU and Global Emergency Care healthcare markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PUPILOSCOPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PUPILOSCOPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More